Robert A Holt

Rob Holt is a basic, translational and clinical research scientist at the British Columbia Cancer Research Institute. He is appointed as Professor of Medical Genetics at the University of British Columbia and Professor of Molecular Biology & Biochemistry at Simon Fraser University. Dr. Holt obtained his PhD in Pharmacology from the University of Alberta and studied molecular evolution at the State University of New York (Albany) as a postdoctoral fellow. He then joined Celera Genomics where he served as the Scientific Operations Manager for initial sequencing of the human genome, and he led international efforts to sequence model organism and pathogen genomes. His team’s current research activities involve immunogenomic analysis, clinical genetic testing, development of cancer vaccines and genetically engineered T cell therapies, biomanufacturing, and health care implementation research. Dr. Holt and co-workers initiated the BioCanRx-supported CLIC (Canadian Led Immunotherapy Collaborative) CAR-T clinical trial program.